Products

Aziderm 20% w/w Cream is a dermatologist-recommended topical medication primarily used to treat mild to moderate acne vulgaris (pimples, blackheads, and whiteheads). Formulated with 20% azelaic acid, this high-strength cream works by destroying acne-causing bacteria, clearing blocked pores, and calming localized skin inflammation.

Augocare-Amoxicillin & Potassium Clavulanate Tablets IP 1000mg (commonly known as Augocare 1000 Duo) is a high-potency combination antibiotic used to treat severe or resistant bacterial infections. It consists of Amoxicillin (an antibiotic that destroys bacteria) and Potassium Clavulanate (a beta-lactamase inhibitor that prevents bacteria from destroying the amoxicillin).

Terbinadoc (containing Terbinafine Hydrochloride) is an oral antifungal medication used to treat a wide variety of persistent fungal infections affecting the skin, hair, and nails. It works by disrupting the fungal cell membrane, killing the fungi and preventing them from spreading.

Monogee 1g Injection is a broad-spectrum cephalosporin antibiotic used to treat severe bacterial infections across multiple parts of the body. It contains Ceftriaxone (1g) as its active ingredient, which works by disrupting the formation of bacterial cell walls, ultimately killing the bacteria.

Cefix 100 mg Tablets (containing Cefixime IP) are primarily used to treat a wide variety of bacterial infections. As a third-generation cephalosporin antibiotic, this medication works by preventing bacteria from forming their protective cell walls, effectively killing them. It only treats bacterial conditions and is completely ineffective against viral infections like the common cold or flu.

QL-300 Tablets contain Quetiapine IP 300 mg, an atypical antipsychotic medication primarily used to treat serious mental health conditions by balancing neurotransmitters like dopamine and serotonin in the brain.

Fulnite 2 mg Tablets are primarily used to treat insomnia (a common sleep disorder) in adults. The active ingredient, Eszopiclone, belongs to a class of medications called sedative-hypnotics. It works by increasing the activity of gamma-aminobutyric acid (GABA) in the brain, slowing down nerve activity to produce a calming effect that induces sleep.

Semasize 1mg (4mg/3ml) is a once-weekly prescription subcutaneous injection containing Semaglutide, used primarily to improve blood sugar control in adults with Type 2 Diabetes Mellitus and for chronic weight management in individuals with obesity or overweight. It belongs to a class of medications called GLP-1 receptor agonists, which mimic a natural hormone that regulates insulin secretion, digestion, and appetite.

Semasize 0.25 mg is a prescription medication containing Semaglutide (1.34 mg/ml in a 2 mg/1.5 ml multi-dose pen), primarily used as an initiation dose to manage Type 2 Diabetes Mellitus and support long-term weight management. This specific 0.25 mg strength is a starting dose meant to help your body adapt to the medicine and minimize digestive side effects before you step up to higher therapeutic doses. It belongs to a class of drugs known as GLP-1 receptor agonists.

Octinib 5.4 mg is a prescription veterinary medication containing Oclacitinib Maleate, primarily used to control severe itching (pruritus) and skin inflammation in dogs. It acts as a selective Janus kinase (JAK) inhibitor, targeting and blocking the specific chemical pathways (cytokines) that trigger allergic itch and inflammation.

Semasize Plus 1.7 mg is a prescription medication containing semaglutide, primarily used for chronic weight management, glycemic control in type 2 diabetes, and reducing cardiovascular risk.

SEMASIZE PLUS 2.4 is a once-weekly subcutaneous prescription injection containing semaglutide, which is primarily used for long-term chronic weight management, cardiovascular risk reduction, and the management of type 2 diabetes. It belongs to a class of medications called GLP-1 receptor agonists, which mimic natural metabolic hormones to regulate appetite, digestion, and blood sugar. The specific formulation of 9.6mg/3ml (3.2mg/ml) provides a multi-dose platform, typically delivering a maintenance dose of 2.4mg per week across four weekly doses.